TIVERTON, ON – January 24, 2022 – Bruce Power and Isogen (a partnership between Kinectrics and Framatome) have completed the installation of a groundbreaking Isotope Production System (IPS), making Unit 7 the first power reactor in the world with installed capability to produce Lutetium-177 (Lu-177). Lu-177 is a medical isotope used in the treatment of … Read more
Valuable isotope used in quantum computing, neutron research, border security and medical imaging Toronto, ON – Laurentis Energy Partners today announced a long-term commercial agreement with Air Liquide for the distribution of Helium-3 (He-3), a rare isotope used in quantum computing, neutron research, border security and medical imaging. Laurentis recently announced its program to produce He-3 in Ontario before … Read more
One of the most prevalently used diagnostic imaging agents in nuclear medicine, helping to detect illnesses like cancer and heart disease Clarington, Ontario – A new program, led by Laurentis Energy Partners and BWXT Medical Ltd. (BWXT Medical), to produce the medical isotope Molybdenum-99 for the first time ever in a power reactor, has gained momentum, receiving … Read more
November 2, 2021: Today in the Ontario legislature, a Private Member’s motion introduced by Bruce-Grey-Owen Sound MPP Bill Walker passed with all party support. The motion asserted Ontario’s global role as a leader in the supply of medical isotopes to fight COVID, keep hospitals safe, and fight cancer. “What makes me so passionate about this … Read more
TORONTO – October 27, 2021 – Laurentis Energy Partners, an innovator and leader in the clean-energy industry, has joined the Canadian Nuclear Isotope Council (CNIC). Laurentis Energy Partners offers expertise in nuclear, hydro, and solar generation, inspections and engineering, nuclear transportation, materials recycling, and medical isotopes. Following the closure of the National Research Universal (NRU) … Read more
October 26, 2021: On Oct. 21, a historic Private Member’s Bill was introduced into the Legislature by Bill Walker, MPP for Bruce-Grey-Owen Sound. The bill asserted Ontario’s global role as a leader in the supply of medical isotopes to fight COVID, keep hospitals safe, and fight cancer. The motion asks government to: “Recognize the supply … Read more
SASKATOON – Iotron Medical Inc. (Iotron) and Canadian Isotope Innovations Corp. (CIIC) are pleased to announce a collaboration to produce the radioisotope copper-67 (Cu-67) for new cancer therapies. This investment will increase the production capacity of the CIIC-operated facilities in Saskatoon, making Cu-67 more widely available to international cancer researchers. Iotron Medical, a spin-out business … Read more
TORONTO – August 24, 2021 – Niagara Energy Products (NEP), a leader in the field of manufacturing radiation shielded containment vessels for isotopes and nuclear contaminated waste, has joined the Canadian Nuclear Isotope Council (CNIC). NEP has a long and storied history in Canada, with three large manufacturing plants in Ontario, providing high-quality jobs in … Read more
Women in Nuclear (WiN) Canada, an association that has been working to support the objectives of WiN Global by emphasizing and supporting the role that women can and do have in addressing public concerns about nuclear energy and the application of radiation and nuclear technology has signed a partnership with the Canadian Nuclear Isotope Council … Read more
McMaster University and Promation have signed a Memorandum of Understanding (MoU) to work together to bring a new medical isotope technology developed at McMaster to the marketplace. At the center of this collaboration is a new technology for producing lutetium-177 (Lu-177), an increasingly sought-after medical isotope. Clinical trials have shown that Lu-177-based drugs have tremendous … Read more